ReviewChemical engineering journal (Lausanne, Switzerland : 1996)2023
Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments.
Review in Chemical engineering journal (Lausanne, Switzerland : 1996), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 156 citations in OpenAlex.
- Construction and Performance Characterization of BiTmFeSbONanomaterials (Basel, Switzerland) · 2025Article
- Claus waste-derived TiOScientific reports · 2025Article
- Enhanced sulfadiazine degradation through synergistic visible light assisted peroxymonosulfate activation using a magnetic Fe₃O₄-ZnIn₂S₄ catalyst.Scientific reports · 2025Article
- Cu-doped ZnO nanoparticles and its application for the photocatalytic degradation of Rhodamine B.Scientific reports · 2025Article
- Advanced TiOMolecules (Basel, Switzerland) · 2025Review
- Empowering wastewater treatment with step scheme heterojunction ternary nanocomposites for photocatalytic degradation of nitrophenol.Scientific reports · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent outbreak of Covid-19 guarantees overconsumption of different drugs as a necessity to reduce the symptoms caused by this pandemic. This triggers the proliferation of pharmaceuticals into drinking water systems. Is there any hope for access to safe drinking water? Photocatalytic degradation using artificial Z-scheme photocatalysts that has been employed for over a decade conveys a prospect for sustainable clean water supply. It is compelling to comprehensively summarise the state-of-the-art effects of Z-scheme photocatalytic systems towards the removal of pharmaceuticals in water. The principle of Z-scheme and the techniques used to validate the Z-scheme interfacial charge transfer are explored in detail. The application of the Z-scheme photocatalysts towards the degradation of antibiotics, NSAIDs, and bacterial/viral inactivation is deliberated. Conclusions and stimulating standpoints on the challenges of this emergent research direction are presented. The insights and up-to-date information will prompt the up-scaling of Z- scheme photocatalytic systems for commercialization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.